Edward White
Stock Analyst at HC Wainwright & Co.
(1.83)
# 3,288
Out of 5,049 analysts
358
Total ratings
29.75%
Success rate
-8.6%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.35 | +348.98% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $8.90 | +91.01% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.95 | +203.03% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.10 | +93.55% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.46 | +995.89% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.49 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $9.34 | +756.53% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.30 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.44 | +481.40% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.78 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.47 | +361.10% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.41 | +362.11% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.20 | +566.67% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $15.42 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.68 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $33.26 | +65.36% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $14.69 | +247.17% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.90 | +42.86% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.22 | +972.80% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.99 | +182.20% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.84 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $8.04 | +8,606.47% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $29.85 | +0.50% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.04 | +1,053.85% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.35
Upside: +348.98%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $8.90
Upside: +91.01%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.95
Upside: +203.03%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.10
Upside: +93.55%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.46
Upside: +995.89%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.34
Upside: +756.53%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.30
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.44
Upside: +481.40%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.78
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.47
Upside: +361.10%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.41
Upside: +362.11%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.20
Upside: +566.67%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $15.42
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.68
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $33.26
Upside: +65.36%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $14.69
Upside: +247.17%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $4.90
Upside: +42.86%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.22
Upside: +972.80%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.99
Upside: +182.20%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.84
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $8.04
Upside: +8,606.47%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $29.85
Upside: +0.50%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.04
Upside: +1,053.85%